Abstract
Proposed strategy to reduce post-transplantation HCV-related disease progression: Marina Berenguer, VAMC/UCSF, San Francisco, CA; Jeffrey Crippin, Washington Univ, San Louis, MO; Nathan Bass, UCSF, San Francisco, CA; Robert Gish, Cal-Pacific Medical Ctr, San Francisco, CA; George Netto, Baylor Medical Ctr, Dallas, TX; Judy Alonzo, VAMC/UCSF, San Francisco, CA; Richard Garcia-Kennedy, Cal-Pacific Medical Ctr, San Francisco, CA; Martin Prieto, La Fe
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
